Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026Unusual Whales·Jul 23 at 04:02 PMKRYS+4.96%
Krystal Biotech updates financial calendar with quarterly results release, conference callPUBT·Jul 23 at 04:01 PMKRYS+4.96%
Is A Single-Patient KB801 Outcome Quietly Reframing Krystal Biotech's Clinical Narrative (KRYS)?Simplywall·Jul 23 at 12:07 AMKRYS+4.96%
Krystal Biotech files patent response citing single-patient KB801 corneal closureTradingView·Jul 21 at 04:33 PMKRYS+4.96%
Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600 | BRK Stock NewsStockTitan·Jul 20 at 08:42 AMTMHC0.00%VVX+4.48%
Krystal Biotech, Inc. Stock 12‑Month Price Target Raised to $369.44, Implies 1% UpsideTradingView·Jul 13 at 02:20 PMKRYS+4.96%
Krystal Biotech Stock And 2 Biotech Names With Pipeline CatalystsSimplywall·Jul 13 at 12:03 AMKRYS+4.96%NTRA-1.51%
Krystal Biotech EVP, General Counsel John C. Thomas disposes of USD 347,270 in common sharesPUBT·Jun 26 at 05:46 PMKRYS+4.96%
